SCHEMBL14922207

SCHEMBL14922207

COc1cc(N)c(N)cc1C(=O)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 6/20 0.43
AURKB Q96GD4 6/20 0.43
CDK1 P06493 5/20 0.43
CCNB1 P14635 5/20 0.43
CDK2 P24941 4/20 0.43
PDPK1 O15530 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
FGFR1 P11362 3/20 0.40
FGFR2 P21802 3/20 0.40
FGFR3 P22607 3/20 0.40
CHEK1 O14757 2/20 0.40
CDK7 P50613 1/20 0.40
KCNH2 Q12809 2/20 0.40
KDR P35968 2/20 0.40
ABCB1 P08183 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13446059 0.95 AURKA (0.42) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8305526 0.94 HTR4 (0.44) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL12582671 0.91 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL12252946 0.90 AURKA (0.44) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL12582585 0.90 AURKA (0.45) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL13545033 0.90 AURKA (0.43) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8305603 0.90 AURKA (0.43) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL12303277 0.90 AURKA (0.43) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL12252754 0.89 AURKA (0.48) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL12772132 0.89 AURKA (0.43) AURKAAURKBCDK1CCNB1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435970-B2 Title compound is drug AT-9283, inhibitor of Cyclin Dependent Kinases (CDK kinases), Aurora kinases and Glycogen Synthase Kinase-3 (GSK3) ASTEX THERAPEUTICS LIMITED (GB) 2013-05-07 US disclosed